Visceral adipose tissue alteration of PI3KR1 expression is associated with gestational diabetes but not promoter DNA methylation

被引:9
作者
Rancourt, Rebecca C. [1 ,2 ]
Ott, Raffael [1 ,2 ]
Schellong, Karen [1 ,2 ]
Melchior, Kerstin [1 ,2 ]
Ziska, Thomas [1 ,2 ]
Henrich, Wolfgang [2 ,3 ]
Plagemann, Andreas [1 ,2 ]
机构
[1] Humboldt Univ, Charite Univ Med Berlin, Div Expt Obstet, Clin Obstet, Berlin, Germany
[2] Berlin Inst Hlth, Berlin, Germany
[3] Humboldt Univ, Charite Univ Med Berlin, Clin Obstet, Berlin, Germany
关键词
Gestational diabetes mellitus; epigenetics; DNA methylation; phosphatidylinositol; 3-kinase; adipose tissue; GENE-EXPRESSION; INSULIN; MELLITUS; PREVALENCE; GLUCOSE; WOMEN; MODEL; BETA;
D O I
10.1080/21623945.2019.1675239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity and diabetes are at an epidemic rate, as well as growing incidences of gestational diabetes mellitus (GDM) which causes pregnancy risks, and harm in both maternal and child health. It remains unclear which molecular mechanisms are driving the functional differences between visceral and subcutaneous fat and how these types directly affect an individual?s health outcome. Paired abdominal subcutaneous and omental visceral adipose tissue were collected from women with GDM (n = 20) and with normal glucose tolerance (NGT, n = 22) during planned caesarian section. Both groups had similar maternal age (average 32.5 years) and BMI at delivery (average 33.3 kg/m(2)). Adipose tissue mRNA expression analyses of insulin signalling genes: PI3KCA, PI3KR1, IRS1 and IRS2 showed significantly decreased PI3KR1 expression (?23%) in visceral fat in GDM with no association to promoter DNA methylation. Reduced visceral fat PI3KR1 expression appears to be a pathogenic factor in GDM but not through altered promoter methylation.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 34 条
[1]  
[Anonymous], DIAB SCHWANG
[2]   Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism [J].
Booth, A. D. ;
Magnuson, A. M. ;
Fouts, J. ;
Wei, Y. ;
Wang, D. ;
Pagliassotti, M. J. ;
Foster, M. T. .
ADIPOCYTE, 2018, 7 (04) :261-272
[3]  
Catalano PM, 2002, AM J PHYSL ENDOCRINO
[4]   Estimated global overweight and obesity burden in pregnant women based on panel data model [J].
Chen, Cheng ;
Xu, Xianglong ;
Yan, Yan .
PLOS ONE, 2018, 13 (08)
[5]  
Chu YL, 2010, J HUAZHONG U SCI-MED, V30, P505, DOI 10.1007/s11596-010-0458-9
[6]   Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus [J].
Colomiere, Michelle ;
Permezel, Michael ;
Riley, Clyde ;
Desoye, Gernot ;
Lappas, Martha .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (04) :567-578
[7]   Nutrigenetics, epigenetics and gestational diabetes: consequences in mother and child [J].
Franzago, Marica ;
Fraticelli, Federica ;
Stuppia, Liborio ;
Vitacolonna, Ester .
EPIGENETICS, 2019, 14 (03) :215-235
[8]   Adipogenesis and metabolic health [J].
Ghaben, Alexandra L. ;
Scherer, Philipp E. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (04) :242-258
[9]   Transcriptional activation of PIK3R1 by PPARγ in adipocytes [J].
Kim, Yoon-Jin ;
Kim, Hyun-Ji ;
Chung, Ki Yong ;
Choi, Inho ;
Kim, Sang Hoon .
MOLECULAR BIOLOGY REPORTS, 2014, 41 (08) :5267-5272
[10]   Gestational diabetes [J].
Kleinwechter, H. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (19) :999-1002